Wanwan Shen

Title: Innovations in Gene Therapy by Wanwan Shen

Introduction

Wanwan Shen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of gene therapy through his innovative research and development. His work focuses on creating compositions that enhance the efficiency of gene delivery systems.

Latest Patents

Wanwan Shen holds a patent for a composition designed for gene therapy or transfection. This composition includes nucleic acid, natural polyphenol, and cationic molecules. The natural polyphenol contains several phenolic hydroxyl groups, which help eliminate free radicals, prevent cancer, fight inflammation, and provide antioxidant features. Compared to the delivery of cationic molecules alone, this composition significantly improves transfection efficiency by about 60-70%. It also reduces the effective transfection dose of cationic molecules by approximately 20 times, thereby minimizing toxicity and enhancing organism compatibility. Importantly, this composition does not introduce other chemical reagents, does not require synthesis, and boasts high biosafety. It can efficiently and safely deliver multiple nucleic acid molecules into cells, making it a promising candidate for treating gene-related diseases.

Career Highlights

Wanwan Shen is affiliated with Shanghai Changzheng Hospital, where he continues to advance his research in gene therapy. His innovative approach has garnered attention in the scientific community, highlighting his commitment to improving medical treatments through technology.

Collaborations

Wanwan Shen collaborates with esteemed colleagues, including Jianru Xiao and Xiaopan Cai. Their combined expertise contributes to the ongoing development of effective gene therapy solutions.

Conclusion

Wanwan Shen's contributions to gene therapy represent a significant advancement in the field. His innovative compositions not only enhance transfection efficiency but also prioritize safety and efficacy in medical applications.